The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute ...

After selling to T-Mobile and Verizon, US Cellular has sold another chunk of its spectrum to AT&T now. Here’s what it could ...

FT836 incorporates multiple next-generation synthetic controls of CAR T-cell function including the Company's novel Sword & ...

AT&T will buy UScellular spectrum including 3.45 GHz and 700 MHz for $1 billion, as the latter prepares to sell its wireless ...

UScellular has confirmed that it will sell a portion of its spectrum assets to AT&T for $1 billion. The announcement of the ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

Amazon UK is currently selling the Momentum 4 for £199, which is the cheapest we've ever seen them. The lowest these ...

An obvious next step in the development and growth of CAR T-cell therapies has been the jump to solid tumors. Because of ...

Mobile’s fixed wireless service for two years. It’s superior to DSL but has some quirks I've discovered along the way.

A couple of months ago, I sat for an interview with Mr Tayo Faloye, the founder of Disability and Sickle Cell Organisation of Nigeria.

ALLO-316, a CD70-targeting CAR T-cell therapy, has demonstrated activity in patients with previously treated, advanced ccRCC.